Preventive effect of l-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 83-86

  Kamei, Junzo ^a   Ohsawa, Masahiro ^a   Miyata, Shigeo ^a   Tanaka, Shun ichi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b Kanazawa Medical Clinic   (Japan)

Author keywords

(Mouse); Diabetes; Hypoalgesia; l Carnosine; Neuropathy

Indexed keywords

POLAPREZINC; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DOSE COMPARISON; DRUG EFFECT; HYPOALGESIA; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SENSORY DYSFUNCTION; STREPTOZOCIN DIABETES; TAIL FLICK TEST;

ADMINISTRATION, ORAL; ANIMALS; CARNOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; HOT TEMPERATURE; MALE; MICE; MICE, INBRED ICR; ORGANOMETALLIC COMPOUNDS; PAIN MEASUREMENT; PAIN THRESHOLD; STREPTOZOCIN; TIME FACTORS; ZINC COMPOUNDS; ZINC SULFATE;

EID: 56149102576     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.002     Document Type: Article

References (31)

1. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205-228
2. Calcutt N.A., Freshwater J.D., and Mizisin A.P. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47 (2004) 718-724
3. +-ATPase activity and glutathione content in diabetic rats. Diabetologia 42 (1999) 1120-1130
4. Cameron N.E., Jack A.M., and Cotter M.A. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic. Biol. Med. 31 (2001) 125-135
5. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., and Yorek M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50 (2001) 1927-1937
6. Dickinson P.J., Carrington A.L., Frost G.S., and Boulton A.J. Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab. Res. Rev. 18 (2002) 260-272
7. Drel V.R., Mashtalir N., Ilnytska O., Shin J., Li F., Lyzogubov V.V., and Obrosova I.G. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55 (2006) 3335-3343
8. Dyck P.J., Dyck P.J., Larson T.S., O'Brien P.C., and Velosa J.A. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23 (2000) 510-517
9. Hipkiss A.R. Would carnosine or a carnivorous diet help suppress aging and associated pathologies?. Ann. N.Y. Acad. Sci. 1067 (2006) 369-374
10. Holliday R., and McFarland G.A. A role of carnosine in cellular maintenance. Biochemistry (Moscow) 65 (2000) 843-848
11. Kakinoki B., Sekimoto S., Yuki S., Ohgami T., Sejima M., Yamagami K., and Saito K. Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes 55 (2006) 616-621
12. 2 receptors. Biochemistry (Moscow) 6 (2000) 938-948
13. Nakamura J., Koh N., Sakakibara F., Hamada Y., Hara T., Sasaki H., Chaya S., Komori T., Nakashima E., Naruse K., Kato K., Takeuchi N., Kasuya Y., and Hotta N. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J. Pharmacol. Exp. Ther. 287 (1998) 897-902
14. Nakamura J., Kato K., Hamada Y., Nakayama M., Chaya S., Nakashima E., Naruse K., Kasuya Y., Mizubayashi R., Miwa K., Yasuda Y., Kamiya H., Ienaga K., Sakakibara F., Koh N., and Hotta N. A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48 (1999) 2090-2095
15. Obrosova I.G., Van Huysen C., Fathallah L., Cao X.C., Greene D.A., and Stevens M.J. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 16 (2002) 123-125
16. O ' Dowd A., O, ' Dowd J.J., and Miller D.J. The dipeptide carnosine constricts rabbit saphenous vein as a zinc complex apparently via a serotonergic receptor. J. Physiol. 495 (1996) 535-543
17. Ohsawa M., and Kamei J. Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 372 (1999) 221-228
18. Ohsawa M., Miyata S., Carlsson A., and Kamei J. Preventive effect of acetyl-l-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 588 (2008) 213-216
19. Pabbidi R.M., Yu S.-Q., Peng S., Khardori R., Pauza M.E., and Premkumar L.S. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol. Pain 4 (2008) 9
20. Prokopieva V.D., Bohan N.A., Johnson P., Abe H., and Boldyrev A.A. Effects of carnosine and related compounds on the stability and morphology of erythrocytes from alcoholics. Alcohol Alcohol. 35 (2000) 44-48
21. Rajanikant G.K., Zemke D., Senut M.C., Frenkel M.B., Chen A.F., Gupta R., and Majid A. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 38 (2007) 3023-3031
22. Scott J.N., Clark A.W., and Zochodne D.W. Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain 122 (1999) 2109-2118
23. Song Z., Fu D.T., Chan Y.S., Leung S., Chung S.S., and Chung S.K. Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress. Mol. Cell. Neurosci. 23 (2003) 638-647
24. Stevens M.J., Li F., Drel V.R., Abatan O.I., Kim H., Burnett D., Larkin D., and Obrosova I.G. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J. Pharmacol. Exp. Ther. 320 (2007) 458-464
25. Thornalley P.J. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int. Rev. Neurobiol. 50 (2002) 37-57
26. Ueki S., Seiki M., Yoneta T., Omata T., Hori Y., Ishikawa M., and Tagashira E. Effect of Z-103 on compound 40/80-induced gastric lesions in rats. Scand. J. Gastroenterol. Suppl. 162 (1989) 202-205
27. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25 (2004) 612-628
28. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
29. Yagihashi S., Yamagishi S.I., Wada R., Baba M., Hohman T.C., Yabe-Nishimura C., and Kokai Y. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124 (2001) 2448-2458
30. Yoshikawa T., Naito Y., Tanigawa T., Yoneta T., and Kondo M. The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)-l-histidinato zinc. Biochim. Biophys. Acta 1115 (1991) 15-22
31. Zochodne D.W., Verge V.M., Cheng C., Sun H., and Johnston J. Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 124 (2001) 2319-2334